Company news
Beijing Konruns Pharmaceutical Co., Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Report for Q3 2025
October 29, 2025
Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders Not Subject to Sales Restrictions Concerning Share Repurchase
October 22, 2025
Announcement on Repurchasing Shares through Call Auction for the 1st Time and Progress in Share Repurchase
October 20, 2025
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale
October 17, 2025
Announcement on Resolutions of the 16th Meeting of the 4th Board of Supervisors
October 15, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
October 13, 2025
Announcement on Release of Pledge of Partial Shares of Controlling Shareholders
October 10, 2025
Announcement on Results of Shareholding Reduction by Senior Management Members
September 30, 2025
Announcement on Receipt of Clinical Trial Approval Notice for KC1036 in Combination with PD-1 Antibody and Platinum-based Chemotherapy as First-Line Treatment for Advanced Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
September 29, 2025
Announcement on Lifting Sales Restrictions and Listing for Circulation in the 2nd Restriction Period for the 1st Grant under 2023 Restricted Stock Incentive Plan
September 16, 2025
Pilot Project of the Center for Drug Evaluation
September 5, 2025
Announcement on Abnormal Fluctuations in Stock Trading
September 1, 2025
Announcement on Lifting Sales Restrictions in the 1st Sales Restriction Period of Reserved Grant under the 2023 Restricted Stock Incentive Plan and Listing of Shares
August 29, 2025
Announcement on Resolutions of the 15th Meeting of the 4th Board of Supervisors
August 27, 2025
Announcement on Completion of the First Subject Enrollment in the Phase 1 Clinical Trial of KC1086
August 21, 2025
Announcement on Resolutions of the 18th Meeting of the 4th Board of Directors
August 11, 2025
Announcement on Foreign Investment by Wholly-owned Subsidiary
July 22, 2025
Announcement on Risk Warning of Stock Trading
July 14, 2025
Announcement on Obtaining Notice of Clinical Trial for Project KC1086
July 2, 2025
Announcement on Resolution of the 14th Meeting of the 4th Board of Supervisors
June 23, 2025